Roche Holding Ag
Apr 23, 2012 at 16:55 | Source: Moneycontrol.com
Mar 23, 2012 at 11:56 | Source: Reuters
Jan 27, 2012 at 21:32 | Source: CNBC-TV18
Apr 12, 2011 at 08:18 | Source: Reuters
Mar 16, 2011 at 16:29 | Source: CNBC-TV18
Feb 02, 2011 at 12:08 | Source: Reuters
Videos »
Photos »
/ 
News across the web »
May 22, 2012 at 16:01 | Source: Wall Street Journal
May 14, 2012 at 14:00 | Source: Bloomberg
May 08, 2012 at 16:17 | Source: Market Watch
May 08, 2012 at 16:02 | Source: Bloomberg
Apr 23, 2012 at 02:00 | Source: Bloomberg
Interact & exchange stock tips & market info »
Related News »
Roche Holding AG (ROG) tightened its bill- collecting policy for hospitals in Spain and Portugal, requiring clinics with the worst arrears to pay down debts before they can get more drugs on credit, and may do the same in Italy. The policy ...
May 28, 2012 at 14:41 | Source: Bloomberg
Roche Holding AG (ROG) is focusing part of its pipeline on the riskiest area of drug development: the human brain. The Swiss drugmaker had its last top-selling brain therapy when Valium revolutionized anxiety treatment in the 1960s. Now Roche is ...
May 12, 2012 at 23:57 | Source: Bloomberg
From Baron Funds' first quarter letter: In January, the Swiss pharmaceutical giant, Roche Holding AG (ROCM), made an all cash offer to acquire Illumina, Inc. (ILMN) for $44.50 per share. While the stock contributed 110 basis points to our ...
May 24, 2012 at 17:59 | Source: GuruFocus
ZURICH May 16 (Reuters) - Roche Holding AG will present late-stage clinical trial data on drugs targeting advanced cancers at a key industry event next month, as it seeks to prove it has enough armoury in its pipeline to protect its oncology franchise.
May 16, 2012 at 05:30 | Source: Reuters
ZURICH -(Dow Jones)- Positive fresh data on Roche Holding AG's (ROG.VX) newest breast cancer drug is expected to be displayed in the U.S. next month at a high-profile medical meeting. Roche is planning to present additional data from key studies ...
May 22, 2012 at 10:59 | Source: Smart Money
CHICAGO (Reuters) - Roche Holding AG's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia - the first such trial to gauge whether early intervention can help prevent or slow the disease.
May 15, 2012 at 15:11 | Source: msnbc.com
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology ...
May 23, 2012 at 16:42 | Source: Financial News Network Online
The numbers are enormous and growing.” Pfizer Inc. (PFE) (PFE), AstraZeneca Plc (AZN) and Roche Holding AG (ROG) had signed confidentiality agreements on Amylin’s sale process, people familiar with the matter said this month. It wasn’t ...
May 25, 2012 at 17:58 | Source: Businessweek
(Reuters) - Roche Holding AG's new drug for advanced melanoma, Zelboraf, on average helped patients with the deadly disease live for more than a year, according to data from a late-stage trial. The results from an abstract, or brief summary ...
May 16, 2012 at 21:58 | Source: msnbc.com
The stock has 14.67% price performance for the year 2012. 5. Roche Holding Ltd (RHHBY.PK): Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated ...
May 27, 2012 at 01:56 | Source: Seekingalpha.com